Healthcare provider profile · identity verified

Bryan W Reed, DO

Internal Medicine · LA CROSSE, WI · NPI 1235357088

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	750	194
Rosuvastatin Calcium	Rosuvastatin Calcium	571	174
Metoprolol Succinate	Metoprolol Succinate	485	135
Losartan Potassium	Losartan Potassium	465	139
Lisinopril	Lisinopril	414	116
Omeprazole	Omeprazole	409	119
Amlodipine Besylate	Amlodipine Besylate	390	111
Levothyroxine Sodium	Levothyroxine Sodium	340	86
Gabapentin	Gabapentin	228	71
Tamsulosin Hcl	Tamsulosin Hcl	226	61
Simvastatin	Simvastatin	219	52
Furosemide	Furosemide	203	61
Eliquis	Apixaban	198	47
Sertraline Hcl	Sertraline Hcl	193	52
Potassium Chloride	Potassium Chloride	163	46
Metformin Hcl	Metformin Hcl	160	42
Finasteride	Finasteride	153	35
Metoprolol Tartrate	Metoprolol Tartrate	153	44
Tramadol Hcl	Tramadol Hcl	149	37
Hydrochlorothiazide	Hydrochlorothiazide	144	43
Allopurinol	Allopurinol	138	32
Metformin Hcl Er	Metformin Hcl	136	40
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	125	39
Trazodone Hcl	Trazodone Hcl	123	40
Fluticasone Propionate	Fluticasone Propionate	121	56
Warfarin Sodium	Warfarin Sodium	119	28
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	115	36
Trulicity	Dulaglutide	109	26
Pantoprazole Sodium	Pantoprazole Sodium	108	31
Xarelto	Rivaroxaban	106	20
Spironolactone	Spironolactone	99	23
Albuterol Sulfate Hfa	Albuterol Sulfate	96	48
Prednisone	Prednisone	95	38
Nitroglycerin	Nitroglycerin	94	46
Clopidogrel	Clopidogrel Bisulfate	88	29
Carvedilol	Carvedilol	87	25
Memantine Hcl	Memantine Hcl	83	18
Duloxetine Hcl	Duloxetine Hcl	78	24
Venlafaxine Hcl Er	Venlafaxine Hcl	76	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	75	21
Escitalopram Oxalate	Escitalopram Oxalate	71	17
Alendronate Sodium	Alendronate Sodium	70	20
Atenolol	Atenolol	69	19
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	69	16
Ezetimibe	Ezetimibe	67	17
Glipizide Er	Glipizide	66	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	66	19
Quetiapine Fumarate	Quetiapine Fumarate	64	16
Ventolin Hfa	Albuterol Sulfate	64	20
Donepezil Hcl	Donepezil Hcl	62	13
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	60	60
Celecoxib	Celecoxib	60	29
Famotidine	Famotidine	59	14
Montelukast Sodium	Montelukast Sodium	56	14
Methocarbamol	Methocarbamol	51	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	20
Torsemide	Torsemide	50	18
Oxycodone Hcl	Oxycodone Hcl	47	15
Propranolol Hcl	Propranolol Hcl	47	12
Bupropion Xl	Bupropion Hcl	46	13
Fluoxetine Hcl	Fluoxetine Hcl	45	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	45	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	45	suppressed
Ramipril	Ramipril	45	suppressed
Ozempic	Semaglutide	44	suppressed
Paroxetine Hcl	Paroxetine Hcl	44	16
Doxazosin Mesylate	Doxazosin Mesylate	43	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	12
Entresto	Sacubitril/Valsartan	41	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	suppressed
Pregabalin	Pregabalin	41	suppressed
Glimepiride	Glimepiride	40	suppressed
Clonazepam	Clonazepam	39	suppressed
Cephalexin	Cephalexin	38	23
Buspirone Hcl	Buspirone Hcl	37	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	14
Triamcinolone Acetonide	Triamcinolone Acetonide	37	30
Jardiance	Empagliflozin	36	suppressed
Fluconazole	Fluconazole	35	13
Chlorthalidone	Chlorthalidone	34	suppressed
Mirtazapine	Mirtazapine	34	14
Glipizide	Glipizide	33	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	32	14
Diazepam	Diazepam	31	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	30	25
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	29	29
Amoxicillin	Amoxicillin	27	19
Mounjaro	Tirzepatide	27	11
Pravastatin Sodium	Pravastatin Sodium	27	11
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	26	suppressed
Baclofen	Baclofen	25	suppressed
Lorazepam	Lorazepam	25	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	11
Symbicort	Budesonide/Formoterol Fumarate	25	suppressed
Loperamide	Loperamide Hcl	24	suppressed
Verapamil Er	Verapamil Hcl	24	suppressed
Azelastine Hcl	Azelastine Hcl	23	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	suppressed
Digoxin	Digoxin	23	suppressed
Farxiga	Dapagliflozin Propanediol	23	suppressed
Humalog Kwikpen U-100	Insulin Lispro	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	21	suppressed
Topiramate	Topiramate	21	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	21	suppressed
Budesonide	Budesonide	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	18	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	18	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	18	14
Spiriva Handihaler	Tiotropium Bromide	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Nystatin	Nystatin	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	11
Clonidine Hcl	Clonidine Hcl	15	suppressed
Estradiol	Estradiol	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Meloxicam	Meloxicam	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Silodosin	Silodosin	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	12	suppressed
Mometasone Furoate	Mometasone Furoate	12	suppressed
Vascepa	Icosapent Ethyl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error